Streamline Health Solutions, Inc.
Streamline Health Solutions, Inc. (STRM) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
strm · pe ratio · data through Jan 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Streamline Health Solutions, Inc. (STRM) measures how much investors pay for each dollar of the company's trailing earnings. STRM's current PE ratio of N/A is calculated by dividing its stock price of $5.33 by its TTM earnings per share of -$0.92.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-01-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 3 fiscal years · Front-end computedMinQ1 · 25%375.4x
MedianQ3 · 75%8064.7x
Max
At N/A, STRM's current P/E is lower than in 0% of its annual fiscal year readings over the past 3 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Streamline Health Solutions, Inc.You STRM | $23M | N/A | — | -$0.92 |
 Akumin Inc. AKU | $26M | N/A | — | -$1.69 |
 Cyclo Therapeutics, Inc. CYTH | $24M | N/A | — | -$1.23 |
 Elevation Oncology, Inc. ELEV | $22M | N/A | — | -$0.78 |
 Elutia Inc. ELUT | $47M | 0.54x | — | $1.29 |
 Invacare Corporation IVC | $25M | N/A | — | -$2.77 |
 LakeShore Biopharma Co., Ltd LSB | $26M | N/A | — | -$0.94 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-01-31Latest FY2025 | — | $-2.53 | — | |
2024-01-31 FY2024 | — | $-0.96 | — | |
2023-01-31 FY2023 | — | $-0.59 | — | |
2022-01-31 FY2022 | — | $-0.36 | — | |
2021-01-31 FY2021 | — | $-2.59 | — | |
2020-01-31 FY2020 | — | $-3.73 | — | |
2019-01-31 FY2019 | — | $-4.50 | — | |
2018-01-31 FY2018 | — | $-2.44 | — | |
2017-01-31 FY2017 | — | $-4.65 | — | |
2016-01-31 FY2016 | — | $-4.52 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Streamline Health Solutions, Inc. (STRM) measures how much investors pay for each dollar of the company's trailing earnings. STRM's current PE ratio of N/A is calculated by dividing its stock price of $5.33 by its TTM earnings per share of -$0.92.
Frequently asked questions
STRM pe ratio · 6 questionsSTRM's current PE ratio is N/A as of 2026-06-09, based on a stock price of $5.33 and TTM EPS of -$0.92. Data sourced from Financial Modeling Prep via STRM's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Streamline Health Solutions, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09